Top

Published in:

01-09-2021 | Coronavirus | Review

Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)

Authors: Biyan Nathanael Harapan, Hyeon Joo Yoo

Published in: Journal of Neurology | Issue 9/2021

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in Wuhan, China in December 2019. It is evident that the COVID-19 pandemic has become a challenging world issue. Although most COVID-19 patients primarily develop respiratory symptoms, an increasing number of neurological symptoms and manifestations associated with COVID-19 have been observed. In this narrative review, we elaborate on proposed neurotropic mechanisms and various neurological symptoms, manifestations, and complications of COVID-19 reported in the present literature. For this purpose, a review of all current published literature (studies, case reports, case series, reviews, editorials, and other articles) was conducted and neurological sequelae of COVID-19 were summarized. Essential and common neurological symptoms including gustatory and olfactory dysfunctions, myalgia, headache, altered mental status, confusion, delirium, and dizziness are presented separately in sections. Moreover, neurological manifestations and complications that are of great concern such as stroke, cerebral (sinus) venous thrombosis, seizures, meningoencephalitis, Guillain–Barré syndrome, Miller Fisher syndrome, acute myelitis, and posterior reversible encephalopathy syndrome (PRES) are also addressed systematically. Future studies that examine the impact of neurological symptoms and manifestations on the course of the disease are needed to further clarify and assess the link between neurological complications and the clinical outcome of patients with COVID-19. To limit long-term consequences, it is crucial that healthcare professionals can early detect possible neurological symptoms and are well versed in the increasingly common neurological manifestations and complications of COVID-19.

Feng W, Zong W, Wang F, Ju S (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review. Mol Cancer 19(1):100. https://doi.org/10.1186/s12943-020-01218-1CrossRefPubMedPubMedCentral

Tsivgoulis G, Palaiodimou L, Katsanos AH, Caso V, Köhrmann M, Molina C, Cordonnier C, Fischer U, Kelly P, Sharma VK, Chan AC, Zand R, Sarraj A, Schellinger PD, Voumvourakis KI, Grigoriadis N, Alexandrov AV, Tsiodras S (2020) Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord. https://doi.org/10.1177/1756286420932036CrossRefPubMedPubMedCentral

Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, Ora J, Mina GG, Puxeddu E, Balbi O, Pezzuto G, Magrini A, Rogliani P, Andreoni M, Mercuri NB (2020) Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.05.037CrossRefPubMedPubMedCentral

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia Ja YuT, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/s0140-6736(20)30211-7CrossRefPubMedPubMedCentral

Sheraton M, Deo N, Kashyap R, Surani S (2020) A review of neurological complications of COVID-19. Cureus 12(5):e8192. https://doi.org/10.7759/cureus.8192CrossRefPubMedPubMedCentral

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.1127CrossRefPubMedPubMedCentral

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58. https://doi.org/10.1016/j.ijid.2020.03.062CrossRefPubMedPubMedCentral

Domingues RB, Mendes-Correa MC, de Moura Leite FBV, Sabino EC, Salarini DZ, Claro I, Santos DW, de Jesus JG, Ferreira NE, Romano CM, Soares CAS (2020) First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease. J Neurol 267(11):3154–3156. https://doi.org/10.1007/s00415-020-09996-wCrossRefPubMedPubMedCentral

Huang YH, Jiang D, Huang JT (2020) SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun 87:149. https://doi.org/10.1016/j.bbi.2020.05.012CrossRefPubMedPubMedCentral

10.

Virhammar J, Kumlien E, Fallmar D, Frithiof R, Jackmann S, Skold MK, Kadir M, Frick J, Lindeberg J, Olivero-Reinius H, Ryttlefors M, Cunningham JL, Wikstrom J, Grabowska A, Bondeson K, Bergquist J, Zetterberg H, Rostami E (2020) Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology 95(10):445–449. https://doi.org/10.1212/WNL.0000000000010250CrossRefPubMedPubMedCentral

11.

Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 12(3):e7352. https://doi.org/10.7759/cureus.7352CrossRefPubMedPubMedCentral

12.

Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92(7):699–702. https://doi.org/10.1002/jmv.25915CrossRefPubMed

13.

Leonardi M, Padovani A, McArthur JC (2020) Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol. https://doi.org/10.1007/s00415-020-09896-zCrossRefPubMedPubMedCentral

14.

Zhou Z, Kang H, Li S, Zhao X (2020) Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. https://doi.org/10.1007/s00415-020-09929-7CrossRefPubMedPubMedCentral

15.

Desforges M, Le Coupanec A, Brison E, Meessen-Pinard M, Talbot PJ (2014) Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 807:75–96. https://doi.org/10.1007/978-81-322-1777-0_6CrossRefPubMedPubMedCentral

16.

Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dube M, Talbot PJ (2019) Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. https://doi.org/10.3390/v12010014CrossRefPubMedPubMedCentral

17.

Chen R, Wang K, Yu J, Chen Z, Wen C, Xu Z (2020) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. bioRxiv. https://doi.org/10.1101/2020.04.07.030650CrossRefPubMedPubMedCentral

18.

Swanson PA 2nd, McGavern DB (2015) Viral diseases of the central nervous system. Curr Opin Virol 11:44–54. https://doi.org/10.1016/j.coviro.2014.12.009CrossRefPubMedPubMedCentral

19.

Amirian ES (2020) Potential fecal transmission of SARS-CoV-2: current evidence and implications for public health. Int J Infect Dis 95:363–370. https://doi.org/10.1016/j.ijid.2020.04.057CrossRefPubMedPubMedCentral

20.

Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, Karim AH, Sattar A (2020) Neurological manifestations of COVID-19 (SARS-CoV-2): a review. Front Neurol. https://doi.org/10.3389/fneur.2020.00518CrossRefPubMedPubMedCentral

21.

Kantonen J, Mahzabin S, Mayranpaa MI, Tynninen O, Paetau A, Andersson N, Sajantila A, Vapalahti O, Carpen O, Kekalainen E, Kantele A, Myllykangas L (2020) Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. https://doi.org/10.1111/bpa.12889CrossRefPubMedPubMedCentral

22.

Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M (2020) SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 350:577436. https://doi.org/10.1016/j.jneuroim.2020.577436CrossRefPubMedPubMedCentral

23.

Cooper KW, Brann DH, Farruggia MC, Bhutani S, Pellegrino R, Tsukahara T, Weinreb C, Joseph PV, Larson ED, Parma V, Albers MW, Barlow LA, Datta SR, Di Pizio A (2020) COVID-19 and the chemical senses: supporting players take center stage. Neuron 107(2):219–233. https://doi.org/10.1016/j.neuron.2020.06.032CrossRefPubMedPubMedCentral

24.

Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Chance R, Macaulay IC, Chou HJ, Fletcher RB, Das D, Street K, de Bezieux HR, Choi YG, Risso D, Dudoit S, Purdom E, Mill J, Hachem RA, Matsunami H, Logan DW, Goldstein BJ, Grubb MS, Ngai J, Datta SR (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. https://doi.org/10.1126/sciadv.abc5801CrossRefPubMed

25.

Fodoulian L, Tuberosa J, Rossier D, Landis BN, Carleton A, Rodriguez I (2020) SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. bioRxiv. https://doi.org/10.1101/2020.03.31.013268CrossRef

26.

Favas TT, Dev P, Chaurasia RN, Chakravarty K, Mishra R, Joshi D, Mishra VN, Kumar A, Singh VK, Pandey M, Pathak A (2020) Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci 41(12):3437–3470. https://doi.org/10.1007/s10072-020-04801-yCrossRefPubMed

27.

Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-05965-1CrossRefPubMedPubMedCentral

28.

Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q, Zeng H, Nisenbaum EJ, Liu L, Zhao Y, Zhang D, Levine CG, Cejas I, Dai Q, Zeng M, Herman P, Jourdaine C, de With K, Draf J, Chen B, Jayaweera DT, Denneny JC 3rd, Casiano R, Yu H, Eshraghi AA, Hummel T, Liu X, Shu Y, Lu H (2020) Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: an international multicenter study. Otolaryngol Head Neck Surg 163(4):714–721. https://doi.org/10.1177/0194599820934376CrossRefPubMedPubMedCentral

29.

Lechien JR, Cabaraux P, Chiesa-Estomba CM, Khalife M, Hans S, Calvo-Henriquez C, Martiny D, Journe F, Sowerby L, Saussez S (2020) Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. https://doi.org/10.1002/hed.26279CrossRefPubMedPubMedCentral

30.

Tsivgoulis G, Fragkou PC, Delides A, Karofylakis E, Dimopoulou D, Sfikakis PP, Tsiodras S (2020) Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19). J Neurol. https://doi.org/10.1007/s00415-020-09935-9CrossRefPubMedPubMedCentral

31.

Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL (2020) Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol 10(8):944–950. https://doi.org/10.1002/alr.22587CrossRefPubMed

32.

Tsai S-T, Lu M-K, San S, Tsai C-H (2020) The neurologic manifestations of coronavirus disease 2019 pandemic: a systemic review. Front Neurol. https://doi.org/10.3389/fneur.2020.00498CrossRefPubMedPubMedCentral

33.

Jiang X, Coffee M, Bari A, Wang J, Jiang X, Huang J, Shi J, Dai J, Cai J, Zhang T, Wu Z, He G, Huang Y (2020) Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity. Comput Mater Contin 62(3):537–551. https://doi.org/10.32604/cmc.2020.010691CrossRef

34.

Lippi G, Wong J, Henry BM (2020) Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med 11(3):193–194. https://doi.org/10.5847/wjem.j.1920-8642.2020.03.013CrossRefPubMedPubMedCentral

35.

Yang X, Yu Y, Xu J, Shu H, Ja X, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475–481. https://doi.org/10.1016/s2213-2600(20)30079-5CrossRefPubMedPubMedCentral

36.

Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, Chen G, Zhang Y, Li D, Li J, Lian H, Niu S, Zhang L, Zhang J (2020) Characteristics of COVID-19 infection in Beijing. J Infect 80(4):401–406. https://doi.org/10.1016/j.jinf.2020.02.018CrossRefPubMedPubMedCentral

37.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/s0140-6736(20)30183-5CrossRefPubMedPubMedCentral

38.

Choi WS, Kang CI, Kim Y, Choi JP, Joh JS, Shin HS, Kim G, Peck KR, Chung DR, Kim HO, Song SH, Kim YR, Sohn KM, Jung Y, Bang JH, Kim NJ, Lee KS, Jeong HW, Rhee JY, Kim ES, Woo H, Oh WS, Huh K, Lee YH, Song JY, Lee J, Lee CS, Kim BN, Choi YH, Jeong SJ, Lee JS, Yoon JH, Wi YM, Joung MK, Park SY, Lee SH, Jung SI, Kim SW, Lee JH, Lee H, Ki HK, Kim YS, Korean Society of Infectious D (2016) Clinical presentation and outcomes of middle east respiratory syndrome in the Republic of Korea. Infect Chemother 48(2):118–126. https://doi.org/10.3947/ic.2016.48.2.118CrossRefPubMedPubMedCentral

39.

Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, Oh DH, Kim JH, Koh B, Kim SE, Yun NR, Lee JH, Kim JY, Kim Y, Bang JH, Song KH, Kim HB, Chung KH, Oh MD, Korea National Committee for Clinical Management of C (2020) Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean Cohort Study on COVID-19. J Korean Med Sci 35(13):e142. https://doi.org/10.3346/jkms.2020.35.e142CrossRefPubMedPubMedCentral

40.

Borge do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT, Marusic A, Jeroncic A, Carvas Junior N, Pericic TP, Zakarija-Grkovic I, Meirelles Guimaraes SM, Luigi Bragazzi N, Bjorklund M, Sofi-Mahmudi A, Altujjar M, Tian M, Arcani DMC, O’Mathuna DP, Marcolino MS (2020) Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med. https://doi.org/10.3390/jcm9040941CrossRef

41.

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 55(3):105924. https://doi.org/10.1016/j.ijantimicag.2020.105924CrossRefPubMedPubMedCentral

42.

Belvis R (2020) Headaches during COVID-19: my clinical case and review of the literature. Headache. https://doi.org/10.1111/head.13841CrossRefPubMedPubMedCentral

43.

Bolay H, Gul A, Baykan B (2020) COVID-19 is a real headache. Headache. https://doi.org/10.1111/head.13856CrossRefPubMedPubMedCentral

44.

Caronna E, Ballve A, Llaurado A, Gallardo VJ, Ariton DM, Lallana S, Lopez Maza S, Olive Gadea M, Quibus L, Restrepo JL, Rodrigo-Gisbert M, Vilaseca A, Hernandez Gonzalez M, Martinez Gallo M, Alpuente A, Torres-Ferrus M, Pujol Borrell R, Alvarez-Sabin J, Pozo-Rosich P (2020) Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia 40(13):1410–1421. https://doi.org/10.1177/0333102420965157CrossRefPubMedPubMedCentral

45.

Singh J, Ali A (2020) Headache as the presenting symptom in 2 patients with COVID-19 and a history of migraine: 2 case reports. Headache 60(8):1773–1776. https://doi.org/10.1111/head.13890CrossRefPubMed

46.

Butt I, Sawlani V, Geberhiwot T (2020) Prolonged Confusional state as first manifestation of COVID-19. Ann Clin Transl Neurol. https://doi.org/10.1002/acn3.51067CrossRefPubMedPubMedCentral

47.

Cipriani G, Danti S, Nuti A, Carlesi C, Lucetti C, Di Fiorino M (2020) A complication of coronavirus disease 2019: delirium. Acta Neurol Belg 120(4):927–932. https://doi.org/10.1007/s13760-020-01401-7CrossRefPubMed

48.

Beach SR, Praschan NC, Hogan C, Dotson S, Merideth F, Kontos N, Fricchione GL, Smith FA (2020) Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry 65:47–53. https://doi.org/10.1016/j.genhosppsych.2020.05.008CrossRefPubMedPubMedCentral

49.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091. https://doi.org/10.1136/bmj.m1091CrossRefPubMedPubMedCentral

50.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585CrossRefPubMedPubMedCentral

51.

Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN (2020) Neurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Front Neurol. https://doi.org/10.3389/fneur.2020.00565CrossRefPubMedPubMedCentral

52.

Kong Z, Wang J, Li T, Zhang Z, Jian J (2020) 2019 novel coronavirus pneumonia with onset of dizziness: a case report. Ann Transl Med 8(7):506. https://doi.org/10.21037/atm.2020.03.89CrossRefPubMedPubMedCentral

53.

Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, Koralnik IJ (2020) Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol 7(11):2221–2230. https://doi.org/10.1002/acn3.51210CrossRefPubMedPubMedCentral

54.

Romero-Sanchez CM, Diaz-Maroto I, Fernandez-Diaz E, Sanchez-Larsen A, Layos-Romero A, Garcia-Garcia J, Gonzalez E, Redondo-Penas I, Perona-Moratalla AB, Del Valle-Perez JA, Gracia-Gil J, Rojas-Bartolome L, Feria-Vilar I, Monteagudo M, Palao M, Palazon-Garcia E, Alcahut-Rodriguez C, Sopelana-Garay D, Moreno Y, Ahmad J, Segura T (2020) Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 95(8):e1060–e1070. https://doi.org/10.1212/WNL.0000000000009937CrossRefPubMedPubMedCentral

55.

Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, Zhou Z, Yang J, Zhong J, Yang D, Guo L, Zhang G, Li H, Xu Y, Chen M, Gao Z, Wang J, Ren L, Li M (2020) Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis 71(15):713–720. https://doi.org/10.1093/cid/ciaa203CrossRefPubMed

56.

Garcia-Azorin D, Martinez-Pias E, Trigo J, Hernandez-Perez I, Valle-Penacoba G, Talavera B, Simon-Campo P, de Lera M, Chavarria-Miranda A, Lopez-Sanz C, Gutierrez-Sanchez M, Martinez-Velasco E, Pedraza M, Sierra A, Gomez-Vicente B, Guerrero A, Ezpeleta D, Penarrubia MJ, Gomez-Herreras JI, Bustamante-Munguira E, Abad-Molina C, Orduna-Domingo A, Ruiz-Martin G, Jimenez-Cuenca MI, Juarros S, Del Pozo-Vegas C, Duenas-Gutierrez C, de Paula JMP, Canton-Alvarez B, Vicente JM, Arenillas JF (2020) Neurological comorbidity is a predictor of death in covid-19 disease: a cohort study on 576 patients. Front Neurol 11:781. https://doi.org/10.3389/fneur.2020.00781CrossRefPubMedPubMedCentral

57.

Pons S, Fodil S, Azoulay E, Zafrani L (2020) The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 24(1):353. https://doi.org/10.1186/s13054-020-03062-7CrossRefPubMedPubMedCentral

58.

Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147. https://doi.org/10.1016/j.thromres.2020.04.013CrossRefPubMedPubMedCentral

59.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418. https://doi.org/10.1016/s0140-6736(20)30937-5CrossRefPubMedPubMedCentral

60.

Al-Ani F, Chehade S, Lazo-Langner A (2020) Thrombosis risk associated with COVID-19 infection A scoping review. Thromb Res 192:152–160. https://doi.org/10.1016/j.thromres.2020.05.039CrossRefPubMedPubMedCentral

61.

Bruggemann R, Gietema H, Jallah B, Ten Cate H, Stehouwer C, Spaetgens B (2020) Arterial and venous thromboembolic disease in a patient with COVID-19: a case report. Thromb Res 191:153–155. https://doi.org/10.1016/j.thromres.2020.04.046CrossRefPubMedPubMedCentral

62.

Valderrama EV, Humbert K, Lord A, Frontera J, Yaghi S (2020) Severe acute respiratory syndrome coronavirus 2 infection and ischemic stroke. Stroke 51(7):e124–e127. https://doi.org/10.1161/STROKEAHA.120.030153CrossRefPubMed

63.

Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148–150. https://doi.org/10.1016/j.thromres.2020.04.041CrossRefPubMedPubMedCentral

64.

Tunc A, Unlubas Y, Alemdar M, Akyuz E (2020) Coexistence of COVID-19 and acute ischemic stroke report of four cases. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2020.05.018CrossRefPubMedPubMedCentral

65.

Escalard S, Chalumeau V, Escalard C, Redjem H, Delvoye F, Hebert S, Smajda S, Ciccio G, Desilles JP, Mazighi M, Blanc R, Maier B, Piotin M (2020) Early brain imaging shows increased severity of acute ischemic strokes with large vessel occlusion in COVID-19 patients. Stroke. https://doi.org/10.1161/STROKEAHA.120.031011CrossRefPubMedPubMedCentral

66.

Jain R, Young M, Dogra S, Kennedy H, Nguyen V, Jones S, Bilaloglu S, Hochman K, Raz E, Galetta S, Horwtiz L (2020) COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 414:116923. https://doi.org/10.1016/j.jns.2020.116923CrossRefPubMedPubMedCentral

67.

Zayet S, Klopfenstein T, Kovacs R, Stancescu S, Hagenkotter B (2020) Acute cerebral stroke with multiple infarctions and COVID-19, France, 2020. Emerg Infect Dis. https://doi.org/10.3201/eid2609.201791CrossRefPubMedPubMedCentral

68.

Rigamonti A, Mantero V, Piamarta F, Spena G, Salmaggi A (2020) Cerebral venous thrombosis associated with coronavirus infection: an underestimated entity? Neurol Sci. https://doi.org/10.1007/s10072-020-04539-7CrossRefPubMedPubMedCentral

69.

Chougar L, Mathon B, Weiss N, Degos V, Shor N (2020) Atypical deep cerebral vein thrombosis with hemorrhagic venous infarction in a patient positive for COVID-19. AJNR Am J Neuroradiol 41(8):1377–1379. https://doi.org/10.3174/ajnr.A6642CrossRefPubMedPubMedCentral

70.

Klein DE, Libman R, Kirsch C, Arora R (2020) Cerebral venous thrombosis: a typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104989CrossRefPubMedPubMedCentral

71.

Shakibajahromi B, Borhani-Haghighi A, Haseli S, Mowla A (2020) Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era. eNeurologicalSci 20:100256. https://doi.org/10.1016/j.ensci.2020.100256CrossRefPubMedPubMedCentral

72.

Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY, American Heart Association Stroke C, the Council on E, Prevention (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(4):1158–1192. https://doi.org/10.1161/STR.0b013e31820a8364CrossRefPubMed

73.

Kow CS, Zaihan AF, Hasan SS (2020) Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105222CrossRefPubMedPubMedCentral

74.

Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18(5):1023–1026. https://doi.org/10.1111/jth.14810CrossRefPubMed

75.

Lyons S, O’Kelly B, Woods S, Rowan C, Brady D, Sheehan G, Smyth S (2020) Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man. Seizure 80:113–114. https://doi.org/10.1016/j.seizure.2020.06.010CrossRefPubMedPubMedCentral

76.

Elgamasy S, Kamel MG, Ghozy S, Khalil A, Morra ME, Islam SMS (2020) First case of focal epilepsy associated with SARS-coronavirus-2. J Med Virol. https://doi.org/10.1002/jmv.26113CrossRefPubMedPubMedCentral

77.

Sohal S, Mansur M (2020) COVID-19 presenting with seizures. IDCases 20:e00782. https://doi.org/10.1016/j.idcr.2020.e00782CrossRefPubMedPubMedCentral

78.

Abdulsalam MA, Abdulsalam AJ, Shehab D (2020) Generalized status epilepticus as a possible manifestation of COVID-19. Acta Neurol Scand. https://doi.org/10.1111/ane.13321CrossRefPubMedPubMedCentral

79.

Somani S, Pati S, Gaston T, Chitlangia A, Agnihotri S (2020) De novo status epilepticus in patients with COVID-19. Ann Clin Transl Neurol 7(7):1240–1244. https://doi.org/10.1002/acn3.51071CrossRefPubMedPubMedCentral

80.

Asadi-Pooya AA (2020) Seizures associated with coronavirus infections. Seizure 79:49–52. https://doi.org/10.1016/j.seizure.2020.05.005CrossRefPubMedPubMedCentral

81.

Ashraf M, Sajed S (2020) Seizures related to coronavirus disease (COVID-19): case series and literature review. Cureus 12(7):e9378. https://doi.org/10.7759/cureus.9378CrossRefPubMedPubMedCentral

82.

Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, Calabresi P (2020) Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure 78:109–112. https://doi.org/10.1016/j.seizure.2020.04.009CrossRefPubMedPubMedCentral

83.

Bhatta S, Sayed A, Ranabhat B, Bhatta RK, Acharya Y (2020) New-onset seizure as the only presentation in a child with COVID-19. Cureus 12(6):e8820. https://doi.org/10.7759/cureus.8820CrossRefPubMedPubMedCentral

84.

Saeed A, Shorafa E (2020) Status epilepticus as a first presentation of COVID-19 infection in a 3 years old boy Case report and review the literature. IDCases. https://doi.org/10.1016/j.idcr.2020.e00942CrossRefPubMedPubMedCentral

85.

Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, Newey CR (2020) Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care. https://doi.org/10.1007/s12028-020-01006-1CrossRefPubMedCentral

86.

Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, Mu J, Guo J, Li W, Wang G, Gao H, Zhang Y, Lin M, Chen L, Shen S, Zhang H, Sander JW, Luo J, Chen S, Zhou D (2020) New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia. https://doi.org/10.1111/epi.16524CrossRefPubMedPubMedCentral

87.

Duong L, Xu P, Liu A (2020) Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.04.024CrossRefPubMedPubMedCentral

88.

Mardani M, Nadji SA, Sarhangipor KA, Sharifi-Razavi A, Baziboroun M (2020) COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect 37:100732. https://doi.org/10.1016/j.nmni.2020.100732CrossRefPubMedPubMedCentral

89.

Bernard-Valnet R, Pizzarotti B, Anichini A, Demars Y, Russo E, Schmidhauser M, Cerutti-Sola J, Rossetti AO, Du Pasquier R (2020) Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur J Neurol. https://doi.org/10.1111/ene.14298CrossRefPubMedPubMedCentral

90.

Benameur K, Agarwal A, Auld SC, Butters MP, Webster AS, Ozturk T, Howell JC, Bassit LC, Velasquez A, Schinazi RF, MullinsHu MEWT (2020) Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA. Emerg Infect Dis 26(9):2016–2021. https://doi.org/10.3201/eid2609.202122CrossRefPubMedPubMedCentral

91.

Al-Olama M, Rashid A, Garozzo D (2020) COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report. Acta Neurochir (Wien) 162(7):1495–1499. https://doi.org/10.1007/s00701-020-04402-wCrossRef

92.

Rahimi K (2020) Guillain–Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci. https://doi.org/10.1007/s10072-020-04693-yCrossRefPubMedPubMedCentral

93.

Khalifa M, Zakaria F, Ragab Y, Saad A, Bamaga A, Emad Y, Rasker JJ (2020) Guillain–Barre syndrome associated with SARS-CoV-2 detection and a COVID-19 infection in a Child. J Pediatric Infect Dis Soc. https://doi.org/10.1093/jpids/piaa086CrossRefPubMedPubMedCentral

94.

Berciano J, Gallardo E (2020) Spinal nerve pathology in Guillain–Barre syndrome associated with COVID-19 infection. Muscle Nerve. https://doi.org/10.1002/mus.27031CrossRefPubMedPubMedCentral

95.

Tiet MY, AlShaikh N (2020) Guillain–Barre syndrome associated with COVID-19 infection: a case from the UK. BMJ Case Rep. https://doi.org/10.1136/bcr-2020-236536CrossRefPubMedPubMedCentral

96.

Sancho-Saldana A, Lambea-Gil A, Liesa JLC, Caballo MRB, Garay MH, Celada DR, Serrano-Ponz M (2020) Guillain–Barre syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection. Clin Med (Lond) 20(4):e93–e94. https://doi.org/10.7861/clinmed.2020-0213CrossRef

97.

Tatu L, Nono S, Gracio S, Kocer S (2020) Guillain–Barre syndrome in the COVID-19 era: another occasional cluster? J Neurol. https://doi.org/10.1007/s00415-020-10005-3CrossRefPubMedPubMedCentral

98.

Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P (2020) COVID-19-associated Guillain–Barre syndrome: the early pandemic experience. Muscle Nerve. https://doi.org/10.1002/mus.27024CrossRefPubMedPubMedCentral

99.

Lascano AM, Epiney JB, Coen M, Serratrice J, Bernard-Valnet R, Lalive PH, Kuntzer T, Hubers A (2020) SARS-CoV-2 and Guillain–Barre syndrome: AIDP variant with favorable outcome. Eur J Neurol. https://doi.org/10.1111/ene.14368CrossRefPubMedPubMedCentral

100.

Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M (2020) New clinical manifestation of COVID-19 related Guillain–Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci 41(7):1657–1658. https://doi.org/10.1007/s10072-020-04484-5CrossRefPubMedPubMedCentral

101.

Ray A (2020) Miller Fisher syndrome and COVID-19: is there a link? BMJ Case Rep. https://doi.org/10.1136/bcr-2020-236419CrossRefPubMedPubMedCentral

102.

Yoshikawa K, Kuwahara M, Morikawa M, Fukumoto Y, Yamana M, Yamagishi Y, Kusunoki S (2018) Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases. Neurol Neuroimmunol Neuroinflamm 5(6):e501. https://doi.org/10.1212/NXI.0000000000000501CrossRefPubMedPubMedCentral

103.

Fernandez-Dominguez J, Ameijide-Sanluis E, Garcia-Cabo C, Garcia-Rodriguez R, Mateos V (2020) Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol. https://doi.org/10.1007/s00415-020-09912-2CrossRefPubMedPubMedCentral

104.

Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M (2020) Guillain–Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. https://doi.org/10.1007/s00415-020-10124-xCrossRefPubMedPubMedCentral

105.

de Silva NL, Weeratunga P, Umapathi T, Malavige N, Chang T (2019) Miller Fisher syndrome developing as a parainfectious manifestation of dengue fever: a case report and review of the literature. J Med Case Rep 13(1):120. https://doi.org/10.1186/s13256-019-2066-zCrossRefPubMedPubMedCentral

106.

Lantos JE, Strauss SB, Lin E (2020) COVID-19-associated Miller Fisher syndrome: MRI findings. AJNR Am J Neuroradiol 41(7):1184–1186. https://doi.org/10.3174/ajnr.A6609CrossRefPubMedPubMedCentral

107.

Zachariadis A, Tulbu A, Strambo D, Dumoulin A, Di Virgilio G (2020) Transverse myelitis related to COVID-19 infection. J Neurol. https://doi.org/10.1007/s00415-020-09997-9CrossRefPubMedPubMedCentral

108.

Chakraborty U, Chandra A, Ray AK, Biswas P (2020) COVID-19-associated acute transverse myelitis: a rare entity. BMJ Case Rep. https://doi.org/10.1136/bcr-2020-238668CrossRefPubMedPubMedCentral

109.

AlKetbi R, AlNuaimi D, AlMulla M, AlTalai N, Samir M, Kumar N (2020) Acute myelitis as a neurological complication of covid-19: a case report and mri findings. Radiol Case Rep. https://doi.org/10.1016/j.radcr.2020.06.001CrossRefPubMedPubMedCentral

110.

Sotoca J, Rodriguez-Alvarez Y (2020) COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000000803CrossRefPubMedPubMedCentral

111.

Chow CCN, Magnussen J, Ip J, Su Y (2020) Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. https://doi.org/10.1136/bcr-2020-236720CrossRefPubMedPubMedCentral

112.

Princiotta Cariddi L, Tabaee Damavandi P, Carimati F, Banfi P, Clemenzi A, Marelli M, Giorgianni A, Vinacci G, Mauri M, Versino M (2020) Reversible encephalopathy syndrome (PRES) in a COVID-19 patient. J Neurol 267(11):3157–3160. https://doi.org/10.1007/s00415-020-10001-7CrossRefPubMedPubMedCentral

113.

Anderson RC, Patel V, Sheikh-Bahaei N, Liu CSJ, Rajamohan AG, Shiroishi MS, Kim PE, Go JL, Lerner A, Acharya J (2020) Posterior reversible encephalopathy syndrome (PRES): pathophysiology and neuro-imaging. Front Neurol 11:463. https://doi.org/10.3389/fneur.2020.00463CrossRefPubMedPubMedCentral

114.

Franceschi AM, Ahmed O, Giliberto L, Castillo M (2020) Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol 41(7):1173–1176. https://doi.org/10.3174/ajnr.A6595CrossRefPubMedPubMedCentral

115.

Dias DA, de Brito LA, Neves LO, Paiva RGS, Barbosa Junior OA, Tavares-Junior JWL (2020) Hemorrhagic PRES: an unusual neurologic manifestation in two COVID-19 patients. Arq Neuropsiquiatr 78(11):739–740. https://doi.org/10.1590/0004-282X20200184CrossRefPubMed

116.

Kishfy L, Casasola M, Banankhah P, Parvez A, Jan YJ, Shenoy AM, Thomson C, AbdelRazek MA (2020) Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. J Neurol Sci 414:116943. https://doi.org/10.1016/j.jns.2020.116943CrossRefPubMedPubMedCentral

117.

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. Lancet Neurol 19(9):767–783. https://doi.org/10.1016/s1474-4422(20)30221-0CrossRefPubMedPubMedCentral

118.

Llorente Ayuso L, Torres Rubio P, Beijinho do Rosario RF, Giganto Arroyo ML, Sierra-Hidalgo F (2020) Bickerstaff encephalitis after COVID-19. J Neurol. https://doi.org/10.1007/s00415-020-10201-1CrossRefPubMedPubMedCentral

119.

Collantes MEV, Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG (2020) Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can J Neurol Sci. https://doi.org/10.1017/cjn.2020.146CrossRefPubMedPubMedCentral

120.

Aksan F, Nelson EA, Swedish KA (2020) A COVID-19 patient with intense burning pain. J Neurovirol. https://doi.org/10.1007/s13365-020-00887-4CrossRefPubMedPubMedCentral

121.

Balestrino R, Rizzone M, Zibetti M, Romagnolo A, Artusi CA, Montanaro E, Lopiano L (2020) Onset of Covid-19 with impaired consciousness and ataxia: a case report. J Neurol. https://doi.org/10.1007/s00415-020-09879-0CrossRefPubMedPubMedCentral

122.

Diezma-Martín MI, García-Alvarado N, Vadillo BA, López-Ariztegui N, Sepúlveda BMA (2020) Tremor and ataxia in COVID-19. Neuralgia Barc Spain. https://doi.org/10.1016/j.nrl.2020.06.005CrossRef

123.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology 296(2):E119–E120. https://doi.org/10.1148/radiol.2020201187CrossRefPubMed

124.

Ghosh R, Dubey S, Finsterer J, Chatterjee S, Ray BK (2020) SARS-CoV-2-associated acute hemorrhagic, necrotizing encephalitis (AHNE) presenting with cognitive impairment in a 44-year-old woman without comorbidities: a case report. Am J Case Rep 21:e925641. https://doi.org/10.12659/AJCR.925641CrossRefPubMedPubMedCentral

125.

Anand P, Zakaria A, Benameur K, Ong C, Putman M, O’Shea S, Greer D, Cervantes-Arslanian AM (2020) Myoclonus in patients with coronavirus disease 2019: a multicenter case series. Crit Care Med. https://doi.org/10.1097/CCM.0000000000004570CrossRefPubMedPubMedCentral

126.

Rabano-Suarez P, Bermejo-Guerrero L, Mendez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sanchez-Tejerina D, Santos-Fernandez T, Folgueira-Lopez MD, Gutierrez-Gutierrez J, Ayuso-Garcia B, Gonzalez de la Aleja J, Benito-Leon J (2020) Generalized myoclonus in COVID-19. Neurology 95(6):e767–e772. https://doi.org/10.1212/WNL.0000000000009829CrossRefPubMedPubMedCentral

127.

Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF (2020) Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. https://doi.org/10.1007/s00401-020-02166-2CrossRefPubMedPubMedCentral

128.

Novi G, Rossi T, Pedemonte E, Saitta L, Rolla C, Roccatagliata L, Inglese M, Farinini D (2020) Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000000797CrossRefPubMedPubMedCentral

129.

Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P, Harpe J, Greer C, Mints G, Salama G, Tsiouris AJ, Leifer D (2020) COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 95(5):221–223. https://doi.org/10.1212/WNL.0000000000009700CrossRefPubMed

130.

Radmanesh A, Derman A, Ishida K (2020) COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy. J Neurol Sci 415:116945. https://doi.org/10.1016/j.jns.2020.116945CrossRefPubMedPubMedCentral

131.

Kaya Y, Kara S, Akinci C, Kocaman AS (2020) Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: case report. J Neurol Sci 413:116858. https://doi.org/10.1016/j.jns.2020.116858CrossRefPubMedPubMedCentral

132.

Fadakar N, Ghaemmaghami S, Masoompour SM, Shirazi Yeganeh B, Akbari A, Hooshmandi S, Ostovan VR (2020) A first case of acute cerebellitis associated with coronavirus disease (covid-19): a case report and literature review. Cerebellum. https://doi.org/10.1007/s12311-020-01177-9CrossRefPubMedPubMedCentral

133.

Bösel J, Berlit P (2020) Neurologische auswirkungen von COVID-19. DGNeurologie. https://doi.org/10.1007/s42451-020-00191-9CrossRefPubMedCentral

134.

Cuhna P, Herlin B, Vassilev K, Kas A, Lehericy S, Worbe Y, Apartis E, Vidailhet M, Dupont S (2020) Movement disorders as a new neurological clinical picture in severe SARS-CoV-2 infection. Eur J Neurol. https://doi.org/10.1111/ene.14474CrossRefPubMed

135.

Ardila A, Lahiri D (2020) Executive dysfunction in COVID-19 patients. Diabetes Metab Syndr 14(5):1377–1378. https://doi.org/10.1016/j.dsx.2020.07.032CrossRefPubMedPubMedCentral

136.

Dugue R, Cay-Martinez KC, Thakur KT, Garcia JA, Chauhan LV, Williams SH, Briese T, Jain K, Foca M, McBrian DK, Bain JM, Lipkin WI, Mishra N (2020) Neurologic manifestations in an infant with COVID-19. Neurology 94(24):1100–1102. https://doi.org/10.1212/WNL.0000000000009653CrossRefPubMedPubMedCentral

137.

Jin M, Tong Q (2020) Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis 26(7):1618–1620. https://doi.org/10.3201/eid2607.200445CrossRefPubMedPubMedCentral

138.

Bagnato S, Boccagni C, Marino G, Prestandrea C, D’Agostino T, Rubino F (2020) Critical illness myopathy after COVID-19. Int J Infect Dis 99:276–278. https://doi.org/10.1016/j.ijid.2020.07.072CrossRefPubMedPubMedCentral

139.

Tankisi H, Tankisi A, Harbo T, Markvardsen LK, Andersen H, Pedersen TH (2020) Critical illness myopathy as a consequence of Covid-19 infection. Clin Neurophysiol 131(8):1931–1932. https://doi.org/10.1016/j.clinph.2020.06.003CrossRefPubMedPubMedCentral

140.

Dalakas MC (2020) Guillain–Barre syndrome: the first documented COVID-19-triggered autoimmune neurologic disease: more to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000000781CrossRefPubMedPubMedCentral

141.

Azouz E, Yang S, Monnier-Cholley L, Arrive L (2020) Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19. Intensive Care Med 46(7):1464–1465. https://doi.org/10.1007/s00134-020-06079-2CrossRefPubMedPubMedCentral

Title: Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)
Authors: Biyan Nathanael Harapan
Hyeon Joo Yoo
Publication date: 01-09-2021
Publisher: Springer Berlin Heidelberg
Keywords: Coronavirus
Guillain-Barré Syndrome
SARS-CoV-2
COVID-19
Headache
Posterior Reversible Encephalopathy Syndrome
Published in: Journal of Neurology / Issue 9/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-021-10406-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2021

A review of mobile stroke units

The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients

William Gordon Lennox (1884–1960)

Transient global amnesia does not increase the risk of subsequent ischemic stroke: a propensity score-matched analysis

Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19

Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms